In a report released today, Sami Corwin from William Blair maintained a Buy rating on Cabaletta Bio (CABA – Research Report). The company’s ...

Cabaletta Bio’s financials and CAR T-cell therapy show potential but face risks. Discover why CABA stock is a risky yet ...

Cabaletta Bio (CABA) announced recent pipeline and operational progress and outlined its strategic priorities and anticipated key milestones ...

The 2025 international signing window opens Wednesday, and this will be perhaps the most interesting period for that since ...

Company plans to meet with the FDA to align on registrational trial designs in 1H25 based on emerging clinical profile of resecabtagene autoleucel (rese-cel, formerly referred to as CABA-201) and ...

The attorney will be sworn in at CABA’s 51st annual installation gala on Saturday, Feb. 8, at the Intercontinental Hotel in ...

The 2025 international signing window opens Wednesday, and this will be perhaps the most interesting period for that since ...

Their top prospect, Andrew Painter, is knocking on the door of finally making his Major League debut. That goes right in line ...

The Phillies avoided salary arbitration with Jesus Luzardo, Ranger Suarez and Bryson Stott by reaching one-year deals on ...

Fintel reports that on December 20, 2024, Evercore ISI Group downgraded their outlook for Cabaletta Bio (NasdaqGS:CABA) from ...

The Prospects Live crew breaks down the tools of their 2nd-ranked player in the Philadelphia Phillies farm system, infield ...

The Marlins acquired Caba and Emaarion Boyd from the Phillies on Sunday in exchange for left-hander Jesus Luzardo (back) and minor-league catcher Paul McIntosh, Mark Feinsand of MLB.com reports.